Targeting SARS-CoV-2 Main protease and variants for effective antiviral development
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:2 publications
Grant number: 202109PJT
Grant search
Key facts
Disease
COVID-19Start & end year
20212026Known Financial Commitments (USD)
$679,893.75Funder
Canadian Institutes of Health Research (CIHR)Research Location
CanadaLead Research Institution
University of AlbertaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen morphology, shedding & natural historySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
2 Publications linked via Europe PMC
Last Updated:4 days ago
View all publications at Europe PMC